Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Carmofur

Carmofur

pharmaceutical raw materials
Carmofur structure

Carmofur 

structure
  • CAS No:

    61422-45-5

  • Formula:

    C11H16FN3O3

  • Chemical Name:

    Carmofur

  • Synonyms:

    1(2H)-Pyrimidinecarboxamide,5-fluoro-N-hexyl-3,4-dihydro-2,4-dioxo-;5-Fluoro-N-hexyl-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinecarboxamide;1-(Hexylcarbamoyl)-5-fluorouracil;1-(n-Hexylcarbamoyl)-5-fluorouracil;HCFU;1-(Hexylcarbamyl)-5-fluorouracil;Carmofur;Mifurol;Yamaful

  • Categories:

    Active Pharmaceutical Ingredients  >  Antineoplastic Agents

Description

Carmofur is a derivative of fluorouracil, an antimetabolite used as an antineoplastic agent. Target: Nucleoside antimetabolite/analogCarmofur, which is used in the clinic to treat colorectal cancers, is a potent AC inhibitor and that this property is essential to its anti-proliferative effects. Carmofur inhibited AC activity with a median effective concentration (IC50) of 29 ± 5 nM (mean ± standard error of the mean, s.e.m.; n = 4), whereas 5-FU had no such effect (IC50>1 mM). systemic a


Carmofur is an organohalogen compound and a member of pyrimidines.|Carmofur is a derivative of fluorouracil, and is an antineoplastic agent that has been used in the treatment of breast and colorectal cancer. Carmofur has been known to induce leukoencephalopathy.|Carmofur is an antimetabolite (pyrimidine analogue) antineoplastic derivative of 5-fluorouracil. (NCI)

Carmofur Basic Attributes

257.26

257.26

1312995-182-4

HA82M3RAB2

758963

DTXSID2045941

C955

L - Antineoplastic and immunomodulating agents

2933599090

Characteristics

78.5

2.6

white to off-white

1.3±0.1 g/cm3

110-111 °C

1.525

DMSO: >15mg/mL

2-8°C

Oral-rat LD50: 268 mg/kg; Oral-Mouse LD50: 1129 mg/kg

Thermal decomposition releases toxic nitrogen oxides and fluoride fumes

Safety Information

6.1

UN 2811 6.1 / PGII

3

60-61-25

45

UV7714000

Xi,T

The warehouse is low-temperature, ventilated and dry; stored separately from food materials

Irritant

P281-P301 + P310

H301-H361

|Danger|H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]|P201, P202, P264, P270, P281, P301+P310, P308+P313, P321, P330, P405, and P501|Aggregated GHS information provided by 39 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Toxicity

highly toxic

Drug Information

Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)

1-hexylcarbamoyl-5-fluorouracil

Carmofur Use and Manufacturing

antineoplastic

Computed Properties

Molecular Weight:257.26
XLogP3:2.6
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:5
Exact Mass:257.11756954
Monoisotopic Mass:257.11756954
Topological Polar Surface Area:78.5
Heavy Atom Count:18
Complexity:382
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Drug Function and Efficacy

This product is a derivative of fluorouracil. It is rapidly absorbed orally and slowly releases fluorouracil in the body, interfering with or blocking the synthesis of DNA, RNA and protein to exert an anti-tumor effect.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

Recommended Suppliers of Carmofur

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.